Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases

NCT02511678

Conditions
Bone Metastasis of Diverse Origins, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Crittenton Hospital Rochester, Michigan, United States
View Trial Details
Completed

Study of Cryoablation for Metastatic Lung Tumors

NCT01957787

Conditions
Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, +8 more
Locations
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • Cancer Treatment Centers of America at Southeastern Regional Medical Center Newnan, Georgia, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

NCT03076216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Cedars Sinai Department of Radiation Oncology Los Angeles, California, United States
  • Moffitt Cancer Centre Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

NCT03003078

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Corrimal Cancer Care Clinic, 20-22 Underwood St Corrimal, New South Wales, Australia
  • Department of Medical Oncology, Royal North Shore Hospital St Leonards, New South Wales, Australia
  • The Kinghorn Cancer Centre, St Vincent's Hospital Sydney, New South Wales, Australia
  • The Crown Princess Mary Cancer Centre, Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Completed

Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab

NCT01276379

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +24 more
Locations
  • Hospital Provincial de Castellón Castellon, Castellón, Spain
  • Hospital Son Espases Palma, Malllorca, Spain
  • Hospital Son Llàtzer Palma, Mallorca, Spain
  • Hospital Sant Joan de Reus Reus, Tarragona, Spain
View all 27 locations
View Trial Details
Completed

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

NCT01343043

Conditions
Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Bethesda, Maryland, United States
View Trial Details
Completed

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

NCT00171158

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +18 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Faber Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Poitiers, France
View Trial Details

Related conditions